Research and Development

Showing 15 posts of 9596 posts found.

No NICE recommendation for AstraZeneca’s Tagrisso in EGFR+ lung cancer

January 22, 2020 Research and Development, Sales and Marketing AstraZeneca, NICE, Tagrisso, pharma

AstraZeneca’s Tagrisso (osimertinib) has been knocked back for routine use on the NHS in England and Wales by the drug …

Novartis establishes its new legal entity in Vietnam

January 22, 2020 Research and Development Novartis, Novartis Vietnam, oncology, pharma

Novartis has inaugurated its new legal entity in Vietnam, Novartis Vietnam Co Ltd, and has become one of the first …
gettyimages-952692342-5c16809146e0fb0001dee456

Collaborating to realise the potential of precision medicine

January 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Precision Medicine, feature, pharma

Healthcare is an evolving continuum, and while traditional strategies have seen improvements to patient outcomes over time, voices in the …
steven_hildemann

Ipsen appoints new Exec VP and Chief Medical Officer

January 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma

Ipsen has named Dr Steven Hildemann as its new Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs …
4420456374_64a3d7e6aa_88_2

Top Ten most popular articles on Pharmafile.com this week

January 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, European Commission, FDA, Pakistan, Sanofi, Teva

Pakistan is cracking down on corruption and has registered cases against 200 pharmaceutical companies, while in the US the FDA …
abbvie_0

AbbVie’s Skyrizi outpaces Novartis’ Cosentyx in plaque psoriasis skin clearance

January 16, 2020 Research and Development AbbVie, Cosentyx, Novartis, Skyrizi, pharma, psoriasis

AbbVie has made it known that Skyrizi (risankizumab) outpaced Novartis’ Cosentyx (secukinumab) at Phase 3 in the treatment of plaque …
dw-anzcxqaqavhl

FDA approves Lannett’s cocaine-based nasal spray

January 15, 2020 Research and Development FDA, Lannett, Numbrino, cocaine

It has been announced that the FDA has moved to approve Lannett Company’s Numbrino (cocaine hydrochloride) nasal solution for “the …
40542895134_9f6048fa40_b

FDA panel votes against Nektar opioid painkiller

January 15, 2020 Research and Development Bernie Opioids, Big Pharma, Trump opioids, opioid, opioid crisis, opioids, pharma

FDA unanimously voted against Nektar Therapeutics opioid pankiller (NKTR-181) for chronic lower back pain, prompting the company to withdraw its …

Pfizer’s Ibrance combo authorised via the Cancer Drugs Fund for advanced breast cancer

January 15, 2020 Research and Development Cancer Drugs Fund, NICE, Pfizer, ibrance, pharma

NICE, the drug watchdog for England and Wales, has given its approval for Pfizer’s Ibrance (palbociclib) in combination with AstraZeneca’s …
131224-f-im476-001

Rochester Drug Cooperative ceases opioid sales following criminal charges

January 15, 2020 Research and Development Bernie Sanders, Trump opioids, opioid, opioid crisis, opioids

The Rochester Drug Cooperative (RDC) has announced it will no longer distribute opioid medications after two of its executives were …
48721589102_164e25393b_b

Democrat Presidential Candidates pledge to lower drug prices without Congress’ help

January 15, 2020 Research and Development Bernie Sanders, GOP, Trump, US President, US Presidential Election, democrats, republican

Two Democratic presidential candidates said that if they are elected president they will act immediately to reduce the cost of …
jp-kress_mor

Working Life Interview: Jean-Paul Kress, CEO of MorphoSys

January 13, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Working Life, feature, morphosys, pharma

With a medical doctorate as well as degrees in pharmacology and immunology under your belt, was your path always to …
4420456374_64a3d7e6aa_88

Top Ten most popular articles on Pharmafile.com this week

January 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The US pharamaceutical industry dominates the news this week, with Pfizer, Sanofi and GlaxoSmithKline all increasing their drug prices while …
novartis_window

Novartis’ ligelizumab tops Xolair in chronic spontaneous urticaria

January 9, 2020 Research and Development Novartis, Xolair, ligelizumab

Novartis has provided a burst of new data directly comparing its therapy ligelizumab with the current standard of care Xolair …
nmpa_logo

China approves first homegrown HPV vaccine

January 8, 2020 Research and Development, Sales and Marketing China, HPV, NMPA, pharma, vaccines

Female patients in China between the ages of nine and 45 will have access to the country’s first domestically-produced vaccine …
The Gateway to Local Adoption Series

Latest content